As of December 31, 2024, Europlasma SA has 52.64M shares outstanding.
| Shares Outstanding | 52.64M |
As of December 31, 2024, Europlasma SA maintains a current ratio of 0.77, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.77 |
| Quick Ratio | 0.03 |
| Debt / Equity | -122.63 |
These figures cover the twelve months ended December 31, 2024.
| Employee Count | 202.00 |
As of the close on October 22, 2026, Europlasma SA's stock has declined approximately 99.96% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.02.
| 52-Week Price Change | -99.96% |
| 200-Day Moving Average | 0.02 |
As of December 31, 2024, Europlasma SA holds 1.75M in cash and equivalents against 13.67M in total debt, resulting in a net debt position of 11.92M. Total book value stands at -10.41M, with working capital of -11.64M providing operational flexibility.
| Cash & Cash Equivalents | 1.75M |
| Total Debt | 13.67M |
| Net Debt | 11.92M |
| Equity (Book Value) | -10.41M |
| Book Value Per Share | -0.20 |
| Working Capital | -11.64M |
Europlasma SA's most recent stock split took place on October 7, 2025.
| Last Split Date | 10/7/2025 |
Already premium?